Tender Details
Tender Title / Description
| Tender Title | The Approval of Veterinary Vaccine Rates (Rate Contract) for year 2025-26 |
|---|---|
| Tender Description | Schedule (A) for H.S.Vaccine HS Vaccine Oil Adjuvant Schedule (C) for remaining other vaccines BQ Vaccine I.P. (Vet)Gel Swine Fever Vaccine IP Freez Dried (Lapinized) Sheep Pox Vaccine IP Freez Dried (Live) Enterotoxaemia Vaccine IP Inactivated and adjuvanated with Aluminum Hydroxide Gel Theileriosis vaccine with diluent Live schizonts of Theileria annuleta grown in cell culture , attenuated vaccine Infectious Bursal Disease IBD Mild Infectious Bursal Disease IBD Intermediate Infectious Bronchitis I.B. Mass N.D. Vaccine Killed Marek's Disease MD HVT Goat Pox Vaccine- I.P. Live attenuated Goat Pox Vaccine (Uttarkashi strain) Grown on Vero Cell Culture. Freeze dried. After reconstitution with respective diluents each dose of 1 ml. should contain not less than 1x10 ³ TCID 50 Goat Pox virus- Porcine cysticercosis recombinant vaccine- Each dose 1 ml contain: Toenia solium oncosphere antigen (TSOL18) ≥150 ng, Thiomersal (as preservative) ≤0.02% w/v, Mineral oil and Phosphate buffer q.s. |
| Comments | Schedule (A) for H.S.Vaccine HS Vaccine Oil Adjuvant Schedule (C) for remaining other vaccines BQ Vaccine I.P. (Vet)Gel Swine Fever Vaccine IP Freez Dried (Lapinized) Sheep Pox Vaccine IP Freez Dried (Live) Enterotoxaemia Vaccine IP Inactivated and adjuvanated with Aluminum Hydroxide Gel Theileriosis vaccine with diluent Live schizonts of Theileria annuleta grown in cell culture , attenuated vaccine Infectious Bursal Disease IBD Mild Infectious Bursal Disease IBD Intermediate Infectious Bronchitis I.B. Mass N.D. Vaccine Killed Marek's Disease MD HVT Goat Pox Vaccine- I.P. Live attenuated Goat Pox Vaccine (Uttarkashi strain) Grown on Vero Cell Culture. Freeze dried. After reconstitution with respective diluents each dose of 1 ml. should contain not less than 1x10 ³ TCID 50 Goat Pox virus- Porcine cysticercosis recombinant vaccine- Each dose 1 ml contain: Toenia solium oncosphere antigen (TSOL18) ≥150 ng, Thiomersal (as preservative) ≤0.02% w/v, Mineral oil and Phosphate buffer q.s. |
Important Dates
| Published Date | |
|---|---|
| Due Date | 14 Aug 2025 12:00:00 |
| Tender Open Date |
Estimate and EMD
| Estimated Value | 0.0 |
|---|---|
| EMD | 1 INR |
| Processing Fee | 29500 INR |